GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Al-Mansour Pharmaceutical Industries (IQS:IMAP) » Definitions » Net Income From Continuing Operations

Al-Mansour Pharmaceutical Industries (IQS:IMAP) Net Income From Continuing Operations : ع.د0.00 Mil (TTM As of . 20)


View and export this data going back to 2004. Start your Free Trial

What is Al-Mansour Pharmaceutical Industries Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Al-Mansour Pharmaceutical Industries's net income from continuing operations for the three months ended in . 20 was ع.د0.00 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in . 20 was ع.د0.00 Mil.

Al-Mansour Pharmaceutical Industries Net Income From Continuing Operations Historical Data

The historical data trend for Al-Mansour Pharmaceutical Industries's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Al-Mansour Pharmaceutical Industries Net Income From Continuing Operations Chart

Al-Mansour Pharmaceutical Industries Annual Data
Trend
Net Income From Continuing Operations

Al-Mansour Pharmaceutical Industries Quarterly Data
Net Income From Continuing Operations

Al-Mansour Pharmaceutical Industries Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was ع.د0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Al-Mansour Pharmaceutical Industries (IQS:IMAP) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Al-Mansour Pharmaceutical Industries (IQS:IMAP) » Definitions » Net Income From Continuing Operations
Comparable Companies
BOM:531521 PTXTQ BIEI STNN XCNQ:BIO XCNQ:WRW BOM:531686 BOM:524606 XCNQ:CANA TSXV:CIP.H BOM:511523 SBFM BOM:524590 BOM:524314 BOM:540359 BOM:533157 BOM:524768 NSE:PARABDRUGS ACCA BOM:524632
Traded in Other Exchanges
N/A
Address
Abu-Graib, Opposite of Belady Milk, Baghdad, IRQ
Website
Al-Mansour Pharmaceutical Industries is a manufacturer of medicines and medical supplies. It develops pharmaceutical supplies, generic drugs, and medical supplies.

Al-Mansour Pharmaceutical Industries (IQS:IMAP) Headlines

No Headlines